SPRY Operating Cash Flow (Statement)
Ars Pharmaceuticals Inc · Operating Cash Flow (Statement)
SPRY Operating Cash Flow (Statement)
Latest reported-$60.93Mperiod ending
SPRY Quarterly Cash from Operations (-$7.63M → -$60.93M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
SPRY operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -60,927,000 | |
| -44,946,000 | |
| -43,485,000 | |
| -47,047,000 | |
| -39,592,000 | |
| -40,742,000 | |
| 42,004,000 | |
| -14,467,000 | |
| -7,279,000 | |
| -6,710,000 | |
| -17,405,000 | |
| -12,763,000 | |
| -16,669,000 | |
| -12,429,000 | |
| -20,497,000 | |
| -5,682,000 | |
| -6,974,000 | |
| -6,925,000 | |
| -21,305,000 | |
| -19,119,000 | |
| -14,135,000 | |
| -12,201,000 | |
| -5,443,000 | |
| -7,628,000 |